Bridget Ziegler
Adult Health · Abington, MANPI 1730547761
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,987 of the $3,071 with a category attached, or 64.7%. 11 manufacturers reported payments, led by Livanova USA, Inc. at 46.8% of the total. Reporting peaked in 2023 at $1,660 and has fallen 73.7% since, to $437 in 2025. Among adult health clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 59 payments — averaging $52.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$1K
- AbbVie$376
- Pfizer$334
- Sanofi$277
- Biohaven Pharmaceuticals, Inc.$228
- Lilly USA, LLC$212
- plus $206 from 5 others
What the payments were for
- Travel & lodging$99132%
- Food & beverage$1,98765%
- Education$933%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 8 | $1,438 |
| AbbVie(2 entities) | 11 | $376 |
| Pfizer | 20 | $334 |
| Sanofi | 3 | $277 |
| Biohaven Pharmaceuticals, Inc. | 4 | $228 |
| Lilly USA, LLC | 8 | $212 |
| E.r. Squibb & Sons, L.L.C. | 1 | $117 |
| Argenx US, Inc. | 1 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Novartis | 1 | $18 |
| Genentech USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,310
- QULIPTA$119
- UBRELVY$119
- ZEPOSIA$117
- NURTEC ODT$105
How this compares
$3,071 in reported general payments places this provider in the 90th percentile of 671 adult health providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Avonex Pen (4 Pack)Interferon Beta-1a | 30 | $261,406 |
| Rebif RebidoseInterferon Beta-1a/Albumin | 13 | $136,158 |
| TecfideraDimethyl Fumarate | 12 | $110,165 |
| FingolimodFingolimod Hcl | 13 | $93,832 |
| CopaxoneGlatiramer Acetate | 13 | $70,957 |
| Nurtec OdtRimegepant Sulfate | 23 | $37,241 |
| Emgality PenGalcanezumab-Gnlm | 47 | $35,089 |
| BotoxOnabotulinumtoxina | 16 | $19,335 |
| UbrelvyUbrogepant | 18 | $19,244 |
| Aimovig AutoinjectorErenumab-Aooe | 19 | $14,353 |
| Emgality SyringeGalcanezumab-Gnlm | 12 | $9,411 |
| Levetiracetam | 288 | $8,963 |
| Gabapentin | 501 | $7,741 |
| Divalproex Sodium ErDivalproex Sodium | 88 | $6,603 |
| Divalproex Sodium | 159 | $6,329 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt, Dilantin | $334 | $42,16950 claims |
| AbbVieBotox, Ubrelvy | $376 | $38,57834 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 671 adult health providers in Massachusetts.
Other adult health in Abington
- Karen FisherAbington$5K
- Krista TuckerBoston$157K
- Kathleen Dietz LovettHyannis$123K
- Caitlin ReenCharlestown$89K
- Tiffini ReedyFall River$58K
- Christine AgiusBoston$32K
- Amy PierreJamaica Plain$27K
- Josie BazemoreBoston$22K
- Jill TerrienWorcester$18K
- Beverly HarrisGroton$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.